4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-055116
President, R&D sold 9,817 shares at an average $22.53 ($221,138)
- President, R&D acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bergstrom Donald A · President, R&D
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-28 | Sale : show line 1 in the form | −1,817 | $21.54 | $39,138 | 86,866 | D |
| 2022-11-01 | Exercise or conversion : show line 2 in the form | +8,000 | $4.12 | $32,960 | 94,866 | D |
| 2022-11-01 | Sale : show line 3 in the form | −8,000 | $22.75 | $182,000 | 86,866 | D |
| Open-market sales · 9,817 sh · avg $22.53 · $221,138 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-01 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −8,000 | 93,456 | D |
Loading xslF345X03/doc4.xml…